ABIGAIL WHITEHEAD: Open Payments
NPI 1841975505 · ALBERTVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$393 in 23 payments from 11 companies in 2025. Trend: 2023 $147 · 2024 $355 · 2025 $393
Food & beverage: $393
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $159 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $35 |
| PFIZER INC. | 2 | $34 |
| Exact Sciences Corporation | 2 | $31 |
| Amgen Inc. | 2 | $29 |
| Astellas Pharma US Inc | 1 | $23 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
| Novartis Pharmaceuticals Corporation | 1 | $16 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
Products named: VRAYLAR, UBRELVY, TRINTELLIX, NURTEC ODT, BOTOX, The Cologuard Plus Collection Kit, OTEZLA, EPKINLY.
Industry payments across AL — which companies pay providers there.
